covance inc (CVD:New York)
Transactions by COVANCE INC (CVD) in the last 6 months
Laboratory Corporation of America acquired Covance Genomics Laboratory LLC from Covance Inc. (NYSE:CVD) on January 31, 2014. Also, Covance entered into a five year services agreement, pursuant to which Covance will collaborate with Laboratory Corporation to continue to offer these services to its clients. Fairmount Partners LP acted as financial advisor for Covance Inc.
Covance Inc. (NYSE:CVD) announces a share repurchase program. Under the program, the company will repurchase shares worth $100 million of its outstanding common stock. The repurchases will be made through open market purchases, privately negotiated transactions, block trades, and 10b5-1 plans. Any purchases under this buyback would be dependent upon business and market conditions and other factors.
The Board of Directors of Covance Inc. have authorized a buyback plan ...
Covance Inc. (NYSE:CVD) announced a private placement of 3.25% senior notes, series 2013A, due November 15, 2018 for $15,000,000, 3.90% senior notes, series 2013B, due November 15, 2020 for $50,000,000, 4.50% senior notes, series 2013C, due November 15, 2023 for $90,000,000, and 4.65% senior notes, series 2013D, due November 15, 2025 for $95,000,000 for aggregate gross proceeds of $250,000,000 on October 2, 2013. The interest on the notes will be payable semiannually, ...
|Charles River Laboratories International Inc||$60.66 USD||+1.18|
|Eurofins Scientific SE||€206.75 EUR||-0.50|
|ICON PLC||$48.37 USD||+0.37|
|PAREXEL International Corp||$55.92 USD||-0.19|
|Quintiles Transnational Holdings Inc||$51.63 USD||+0.39|
|View Industry Companies|